Our Portfolio

Atonarp Inc.

Outline Development, manufacture, and sales of analytical equipment


Industry Electronic devices
Commercialization stage Early stage

Provided Support

  • Develops analytical equipment that enables high-accuracy, real-time molecular measurement over an extended period of time
  • Aims to improve the quality of life of patients and healthcare professionals by developing equipment for simultaneous analysis of multiple components, including blood, immediately and without pain
  • Strengthens international competitiveness through open innovation with companies involved in electronics, pharmaceuticals, and other sectors
Authorized Investment USD 7.5 million (maximum) / USD 8 million (maximum)
Announcement Date July 19, 2016/August 22, 2019
Investment Structure
About Us
Our Business
Our Investments